ArticleBiomedicines2026

Circulating GDF15 and HbA1c Response to Add-On Exenatide Therapy in Type 2 Diabetes: A Post Hoc Analysis from a Multicenter Trial.

Qi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.